Mulvihill U.S. Health Care Enhanced Yield ETF Announces Year End Results

(TSX: XLVE)

Mulvihill U.S. Health Care Enhanced Yield ETF (the “Fund”) announces results of operations for the year ended December 31, 2023. Decrease in net assets attributable to holders of units amounted to $0.51 million or $0.74 per unit. As at December 31, 2023, net assets attributable to holders of units were $6.41 million or $8.55 per unit. Cash distributions to unitholders totaling $0.45 million or $0.64 per unit were paid during the period.

The Fund is a mutual fund investment trust that seeks to provide unitholders with long-term capital appreciation through exposure to a portfolio consisting principally of U.S. Health Care issuers selected from the S&P 500 Index that are classified as “health care” by Standard and Poor’s Global Industry Classification Standard and monthly cash distributions.

In order to achieve its investment objectives, the Fund will purchase and hold substantially all of its assets comprised principally of securities from the S&P 500 Health Care Index, while adding modest leverage of 25.0 percent. The Fund will also write call and put options on a portion of its portfolio to seek to generate investment returns and, in the case of put options, acquire securities at predetermined prices in a manner that reduces acquisition costs. The Fund seeks to achieve a 7.0 percent yield, with additional capital growth potential beyond such yield target.

The Fund’s investment portfolio is managed by its investment manager, Mulvihill Capital Management Inc. The Fund’s Units are listed on the Toronto Stock Exchange under the symbol XLVE.

Selected Financial Information: ($ Millions)
Statement of Financial Position as at December 31st	2023
Assets	$	6.50
Liabilities		(0.09	)
Net Assets Attributable to Holders of Units	$	6.41
Statement of Comprehensive Income for the year ended December 31st
Loss (including Net Loss on Investments)	$	(0.22	)
Expenses		(0.29	)
Decrease in Net Assets Attributable to Holders of Units	$	(0.51	)

For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at [e-mail] or visit Mulvihill www.mulvihill.com.

John Germain, Senior Vice-President & CFO	Mulvihill Capital Management Inc. 121 King Street West Suite 2600 Toronto, Ontario, M5H 3T9 416.681.3966; 1.800.725.7172

Commissions, trailing commissions, management fees and expenses all may be associated with investment funds. Please read the prospectus before investing. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.